Catalog No.
RHG14701
Species reactivity
Human
Host species
Mouse
Isotype
IgG1
Clonality
Monoclonal
Tested applications
ELISA: 1:10000, FCM: 1:200-1:400
Target
M-phase phosphoprotein 2, HFH-11, Winged-helix factor from INS-1 cells, HNF-3/fork-head homolog 11, MPP2, Hepatocyte nuclear factor 3 forkhead homolog 11, Forkhead box protein M1, WIN, Forkhead-related protein FKHL16, FOXM1, FKHL16, HFH11, MPM-2 reactive phosphoprotein 2, Transcription factor Trident
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
Q08050
Applications
ELISA, FCM
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% Sodium Azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
R3R62
Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical Studies., PMID:39829438
Role of ADAM10/17-Mediated Cleavage of LAG3 in the Impairment of Immunosuppression in Psoriasis., PMID:39571889
Synthesis of Novel Acetyl-11-keto-β-boswellic Acid Derivatives as Potential Anti-GBM Agents., PMID:38302832
Identification of novel tumor-associated antigens and evaluation of a panel of autoantibodies in detecting oral cancer., PMID:37641028
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab., PMID:37557179
18F-Fluoromisonidazole-Positron Emission Tomography and Immunohistochemistry Verified Tumor Oxygenation, Stemness, and Immunosupportive Microenvironment After Preoperative Neoadjuvant Bevacizumab for Newly Diagnosed Glioblastoma., PMID:37187346
Comprehensive immunohistochemical analysis based on the origin of leiomyosarcoma., PMID:36734438
A novel combination treatment of antiADAM17 antibody and erlotinib to overcome acquired drug resistance in non-small cell lung cancer through the FOXO3a/FOXM1 axis., PMID:36456730
Multiplexed immunofluorescence analysis of CAF-markers, EZH2 and FOXM1 in gastric tissue: associations with clinicopathological parameters and clinical outcomes., PMID:36401232
Characterizing and Targeting Genes Regulated by Transcription Factor MYBL2 in Lung Adenocarcinoma Cells., PMID:36291764
Peptide-based PROTAC degrader of FOXM1 suppresses cancer and decreases GLUT1 and PD-L1 expression., PMID:36171633
FOXM1 Inhibition Enhances the Therapeutic Outcome of Lung Cancer Immunotherapy by Modulating PD-L1 Expression and Cell Proliferation., PMID:35975458
FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome Inhibition., PMID:35955438
Oncofetal proteins and cancer stem cells., PMID:35670043
Estrogen Receptor-Beta2 (ERβ2)-Mutant p53-FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC)., PMID:35267428
Peptide-Based Vaccines for Hepatocellular Carcinoma: A Review of Recent Advances., PMID:34513746
Endothelial Autocrine Signaling through CXCL12/CXCR4/FoxM1 Axis Contributes to Severe Pulmonary Arterial Hypertension., PMID:33804745
In search for biomarkers and potential drug targets for uterine serous endometrial cancer., PMID:33754208
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models., PMID:33660397
Interferon α Enhances B Cell Activation Associated With FOXM1 Induction: Potential Novel Therapeutic Strategy for Targeting the Plasmablasts of Systemic Lupus Erythematosus., PMID:33633721
A cytoskeleton regulator AVIL drives tumorigenesis in glioblastoma., PMID:32651364
Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs., PMID:32153563
[Corrigendum] The pterocarpanquinone LQB-118 induces apoptosis in acute myeloid leukemia cells of distinct molecular subtypes and targets FoxO3a and FoxM1 transcription factors., PMID:31545420
Heme oxygenase-1 attenuates seawater drowning-induced acute lung injury through a reduction in inflammation and oxidative stress., PMID:31254959
Molecular pathology of the luminal class of urothelial tumors., PMID:31232464
Promyelocytic leukemia protein (PML) controls breast cancer cell proliferation by modulating Forkhead transcription factors., PMID:30927552
Corneal Oxidative Damage in Keratoconus Cells due to Decreased Oxidant Elimination from Modified Expression Levels of SOD Enzymes, PRDX6, SCARA3, CPSF3, and FOXM1., PMID:30820289
Immunohistochemical Study of Mitosis-regulatory Proteins in Gastroenteropancreatic Neuroendocrine Neoplasms., PMID:29970506
Decreased osteoprogenitor proliferation precedes attenuation of cancellous bone formation in ovariectomized rats treated with sclerostin antibody., PMID:29955626
Studying Protein-Protein Interactions by Biotin AP-Tagged Pulldown and LTQ-Orbitrap Mass Spectrometry., PMID:28808999
The addition of celecoxib improves the antitumor effect of cetuximab in colorectal cancer: role of EGFR-RAS-FOXM1-β- catenin signaling axis., PMID:28423516
Expression and potential correlation among Forkhead box protein M1, Caveolin-1 and E-cadherin in colorectal cancer., PMID:27698803
In Vitro Methods for Studying the Mechanisms of Resistance to DNA-Damaging Therapeutic Drugs., PMID:26910067
Systematic transcriptome analysis reveals tumor-specific isoforms for ovarian cancer diagnosis and therapy., PMID:26015570
Immunohistochemistry-based prognostic biomarkers in NSCLC: novel findings on the road to clinical use?, PMID:25599124
Insulin-like growth factor-1 receptor signaling increases the invasive potential of human epidermal growth factor receptor 2-overexpressing breast cancer cells via Src-focal adhesion kinase and forkhead box protein M1., PMID:25391374
Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia., PMID:25365263
Differential effects of targeting Notch receptors in a mouse model of liver cancer., PMID:25311838
DNA microarray and signal transduction analysis in pulmonary artery smooth muscle cells from heritable and idiopathic pulmonary arterial hypertension subjects., PMID:25290246
Targeted therapy: tailoring cancer treatment., PMID:23823626
MEK inhibition increases lapatinib sensitivity via modulation of FOXM1., PMID:23531216
3, 3'-Diindolylmethane enhances the effectiveness of herceptin against HER-2/neu-expressing breast cancer cells., PMID:23372748
The expression of Nek7, FoxM1, and Plk1 in gallbladder cancer and their relationships to clinicopathologic features and survival., PMID:23359173
Negative regulation of transcription factor FoxM1 by p53 enhances oxaliplatin-induced senescence in hepatocellular carcinoma., PMID:23262037
Two mechanisms regulate keratin K15 expression in keratinocytes: role of PKC/AP-1 and FOXM1 mediated signalling., PMID:22761689
The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia., PMID:20823107
B-Myb is critical for proper DNA duplication during an unperturbed S phase in mouse embryonic stem cells., PMID:20715180
The ultrastructural study of tumorigenic cells using nanobiomarkers., PMID:20578834
FoxM1 mediates resistance to herceptin and paclitaxel., PMID:20530690
Hyperglycemia in vitro up-regulates growth-related cell cycle proteins of adult mouse pancreatic islets., PMID:19249551
For research use only. Not for human or drug use.
